News
New AMA analysis of consolidation in PBM markets
Pharmacy Benefit Managers: Not Campaign Fodder So Far. But the Push for Reform May Be Gaining Traction
The Biden-Harris Administration Must Side With Patients Against Big Insurers' Illegal Greed
PBMs are Misleading America
Parties Agree — Lawmakers Need to Stop Drug Price Manipulation
Untangling The $500 Billion PBM Web: The Opaque Relationship Between Employers And Drug Middlemen
National Poll of Likely 2024 Voters Shows Strong Bipartisan Support for Specific PBM Reform Policies and Candidates Who Support Them
Drug middlemen say Pharma sets prices. Then why do middlemen have hundreds for the same drug?
PBM Accountability Project Members Host Important PBM Discussion on Capitol Hill
House hearing keeps pressure on PBM practices while Congress considers reforms
Medication middlemen face bipartisan criticism as Congress eyes industry reforms
PBM Accountability Project Statement on FTC Interim Report on PBMs
F.T.C. Says Middlemen Appear to Be Driving Up Drug Prices
Big Pharmacy-Benefit Managers Increase Drug Costs, FTC Says
FTC report finds PBMs profit at the expense of patients and independent pharmacies
Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite.
New York Times Investigation Shows PBMs Rip Off Just About Everyone
Watch: How pharmacy benefit managers influence drug pricing
Watch: The role of PBMs, patents, and public health in drug pricing
Bipartisan bill will bring prescription drug costs down (opinion)
Rural pharmacies fill a health care gap in the US. Owners say it’s getting harder to stay open
Burdensome step therapy requirements could delay care for cancer patients: analysis
Pharmacy Closures Spark Need for PBM Reform
Senators See Possible Conflicts of Interest in Health Care Pricing Tools